Satake, Hironaga http://orcid.org/0000-0001-7629-6803
Tsuji, Akihito
Nakamura, Masato
Ogawa, Masaaki
Kotake, Takeshi
Hatachi, Yukimasa
Yasui, Hisateru
Takagane, Akinori
Okita, Yoshihiro
Nakamura, Kumi
Onikubo, Toshihide
Takeuchi, Masahiro
Fujii, Masashi
Funding for this research was provided by:
Japan Clinical Cancer Research Organization
Article History
Received: 25 September 2017
Accepted: 15 December 2017
First Online: 20 February 2018
Compliance with ethical standards
:
: Hironaga Satake has received honoraria from Bayer, Chugai Pharma, Eli Lilly Japan, Merck Serono, Takeda, Taiho Pharmaceutical, and Yakult Honsha. Akihito Tsuji has received honoraria from Chugai Pharma, Takeda Pharmaceutical, Eli-Lilly, Taiho Pharma, Bayer, Bristol-Myers Squibb Japan, Daiichi Sankyo, and Merck Serono. Masato Nakamura has received honoraria from Merck Serono, Taiho Pharma, and Yakult Honsha. Masahiro Takeuchi has received consulting fees from Taiho Pharmaceutical, Shionogi, AbbVie GK, Astra Zeneca Co., Hisamitsu Pharma Co., and Mitsubishi Tanabe Pharma.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.